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OBJECTIVE  
The use of colonoscopy as a primary screening test for colorectal cancer (CRC) in 
average risk adults is a subject of controversy. Our primary objective was to build a 
predictive model based on a few simple variables that could be used as a guide for 
identifying average risk adults more suitable for examination with colonoscopy as a 
primary screening test. 
 
METHODS  
The prevalence of advanced adenomas was assessed by primary screening colonoscopy 
in 2210 consecutive adults at least 40 yr old, without known risk factors for CRC. Age, 
gender, and clinical and biochemical data were compared among people without 
adenomas, those with nonadvanced adenomas, and those with any advanced neoplasm. 
A combined score to assess the risk of advanced adenomas was built with the variables 
selected by multiple logistic regression analysis. 
 
RESULTS  
Neoplastic lesions were found in 617 subjects (27.9%), including 259 with at least one 
neoplasm that was 10 mm or larger, villous, or with moderate-to-severe dysplasia, and 
11 with invasive cancers. Advanced lesions were more frequent among men, older 
people, and those with a higher body mass index (BMI). These three variables were 
independent predictors of advanced adenomas in multivariate analysis. A score 
combining age, sex, and BMI was developed as a guide for identifying individuals more 
suitable for screening colonoscopy. 
 
CONCLUSIONS 
Age, gender, and BMI can be used to build a simple score to select those average risk 
adults who might be candidates for primary screening colonoscopy.  
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INTRODUCTION 
 
Colorectal cancer (CRC) is the second most frequent cause of cancer-related death in 
western countries (1). Most cancers develop from benign adenomatous polyps (2, 3), in 
subjects with no known risk factors for the disease (4). Although it is not yet possible to 
determine which adenomas will progress to cancer, certain pathological features have 
been found to correlate with the risk of progressing to CRC (3, 5). “Advanced 
adenomas” have been defined as those with at least one of the following characteristics: 
size 1 cm or larger, tubulovillous or villous histology, and moderate or severe dysplasia 
(6–9). 
 
Screening with full colonoscopy as a primary procedure has been limited to a few small 
series (10–16), and results have not been focused in advanced adenomas. Two large 
colonoscopic series recently published (17, 18) have assessed the proportion of 
advanced proximal adenomas in average risk adults. Although the prevalence of colonic 
adenomas is higher among men than among women (5, 12, 19, 20) and increases with 
age (11, 13, 15), more data are needed to adequately assess the independent role of the 
most relevant predictors of advanced adenomas (18). A variety of factors have been 
linked to the development of adenomas or CRC (21–25), but currently there is no 
dominant risk factor that could be practically used for risk stratification in screening for 
neoplasia among average risk adults without known family history of CRC. Abdominal 
symptoms with no evidence of bleeding have been considered a poor indication for 
colonoscopy in series with small numbers of patients (26–29). Clarification of the 
relative impact of these and other variables on the risk of advanced adenomas in average 
risk persons is needed, because such clarification might provide basis to design more 
efficient CRC screening strategies. 
 
We performed total colonoscopy in a large series of average risk subjects without any 
symptoms suggesting colonic neoplasm, to establish the prevalence of advanced 
adenomas and to analyze which clinical and biochemical data could predict their 
presence in these patients. Our primary objective was to build a predictive model based 
on a few simple variables which, having significant associations with the presence of 
advanced neoplasms, could at the same time be easily obtained for each patient. This 
model could be used as a guide for identifying adults more suitable for examination 
with colonoscopy as a primary screening test. 
 
 
MATERIALS AND METHODS 
 
Study Design 
From 1988 to 1998, full colonoscopy was performed as a primary screening procedure 
in all consecutive patients 40 yr of age or older, without family history of CRC or any 
symptom suggesting colonic neoplasm, who were referred to our endoscopy unit for 
CRC screening. The study protocol was approved by a central human-rights committee, 
and written informed consent was obtained in all cases. 
 
Patients were recruited in one of two ways: 1) if they came for a routine health check-
up, or 2) if they were attending medical clinics for follow-up of stable medical 
problems. All the patients provided a routine medical history and underwent physical 
examination before the colonoscopy. Clinical and biochemical data were recorded as 
shown in Table 1. Body mass index (BMI: weight in kilograms/squared height in 
meters) was used to measure body fat. 
 
Any subject who underwent colonoscopy but had reported hematochezia, a change in 
bowel habit, development of persistent abdominal or rectal pain (in the year before 
colonoscopy) was excluded. Other exclusion criteria were iron deficiency anemia, 
weight loss, previous colon polyps or cancer, any first degree relative(s) with colon 
cancer, previous breast or uterine cancer, inflammatory bowel disease, previous 
abdominal radiation, colonoscopy or barium enema within 5 yr performed for any 
indication, and use of anticoagulants. Subjects who had an incomplete colonoscopy 
were excluded from the analysis. Fecal occult blood testing was not performed before 
colonoscopic screening. 
 
Patients were prepared for colonoscopy by administration of PEG-electrolyte GI lavage 
or oral phosphosoda. Colonos-copies were performed by staff gastroenterologists or 
gastroenterology fellows under the supervision of a staff gastroenterologist, with the 
Olympus CF-V10L, CF-100HL, CF-130L, or CFQ-140L (Olympus Europa, Barcelona, 
Spain) colonoscopes. Meperidine plus midazolam or propofol were used as needed for 
sedation. All polyps were removed with standard polypectomy snares. 
 
The following endoscopic findings were assessed: 1) location of each colorectal 
neoplasm (cancer or polyp) according to the distance from the anal verge, as measured 
with markings on the endoscope, and 2) size of each polyp (when seen intact or first 
removed). 
 
Standard methods were used for histologic assessment, with all polyps fixed in 10% 
formol saline, totally embedded, and routinely stained with hematoxylin and eosin (30, 
31), and were diagnosed according to the criteria of the World Health Organization by 
pathologists with a special expertise in GI pathology. Dysplasia was graded as mild, 
moderate, or severe (32). Patients with intramucosal carcinoma or carcinoma in situ 
were classified as having severe dysplasia (30). CRC was defined as the invasion of 
malignant cells beyond the muscularis mucosa. 
 
Patients with multiple adenomas were categorized according to the largest tumor 
diameter, the most villous histology, and the most severe grade of dysplasia. 
To make our data comparable with other studies (6–9, 15, 17), we considered two 
definitions of “advanced adenoma”: 1) “broad definition,” if any of the following 
criteria were fulfilled for any adenoma: size 1 cm or larger, villous (or tubulovillous) 
histology, and moderate or severe grade of dysplasia; and 2) “restricted definition” in 
which moderate dysplasia was excluded (i.e., only severe dysplasia was considered). 
 
Statistical Analysis 
We compared clinical and biochemical data of patients with no adenomas, patients with 
nonadvanced adenomas, and patients with at least one advanced colonic adenoma. 
Chisquared test for linear trend and one-way analysis of variance were used for 
between-group comparisons. A p value of less than 0.05 was considered statistically 
significant. Multiple logistic regression was used to identify independent predictors of 
advanced adenomas. Two different logistic regression models were constructed, 
depending on the criteria for advanced lesion (“broad” or “restricted” criteria, see 
above) used as the dependent variable. 
The independent variables were selected according to the purposeful method (33). 
Initial candidate variables were those withp < 0.25 in the univariate analysis. We 
examined whether there was any significant interaction (effect modification) between 
every two independent variables included in multivariate analysis. 
 
A receiver operating characteristic (ROC) plot was constructed, and the area under the 
curve was estimated to assess the degree of discrimination provided by the model (34). 
To predict the presence of advanced neoplasms in a given individual, a diagnostic score 
was designed with the independent variables selected by the multivariate analysis. 
Continuous variables were converted into categoric variables. A new logistic regression 
model was run with these transformed variables. The coefficients yielded by the model 
were rounded to the nearest half integer and then multiplied by 2 to avoid decimals. A 
score for each subject was computed. The validity of the score was assessed by ROC 
analysis. 
 
 
RESULTS 
 
Characteristics of Patients With and Without Advanced Adenomas 
From 1988 to 1998, 2260 consecutive average risk persons underwent primary 
colonoscopic screening. Colonoscopy was completed to cecum in 2210 patients 
(97.8%), who were included in our analysis. Characteristics of the study population are 
shown in Table 1. Their mean age was 57.9 yr (SD = 8.6); 74.6% were men. 
 
Patients were classified on the basis of the most advanced lesion (Table 2). No polypoid 
lesions were found in 1385 patients (62.7%). Among the other 825 (37.3%), 2210 
polyps were removed. Six hundred seventeen patients (27.9%) had adenomas of any 
type or invasive cancer. Advanced disease (defined as an adenoma 10 mm or larger, or 
with villous features, moderate-to-severe dysplasia, or invasive cancer) was present in 
259 patients (11.7%). In 54 (2.4%) the most advanced lesion were tubular adenomas 10 
mm or larger. Ninety patients (4.0%) had adenomas with villous features, 153 (6.9%) 
had adenomas with moderate dysplasia, and 27 (1.2%) had adenomas with severe 
dysplasia or invasive cancer. Among the 11 patients with invasive cancer (mean age 
66.6 yr; 10 male), the stage was T1N0 in four, T2N0 in two, and T3N0 in three; two 
patients had nodal involvement, and none had metastatic disease. Five patients had 
cancers proximal to the splenic flexure. 
 
When moderate dysplasia was accepted as a criterion for “advanced lesion” (Table 3), 
68 patients (26.3%) had advanced lesions only in the proximal colon, 137 (52.9%) had 
advanced disease only in the distal colon (i.e., distal to the splenic flexure), and 54 
(20.8%) had advanced neoplasms in both the distal and the proximal colon. When the 
“restricted” definition for advanced adenoma was applied (Table 3), 37 patients (23.7%) 
had advanced lesions only in the proximal colon, 100 had advanced disease only in the 
distal colon (64.1%), and 19 (12.2%) presented advanced neoplasms in both colonic 
segments. 
 
Comparisons of clinical and biochemical data of patients according to the existence and 
severity colonic adenomas are shown in Table 4. Nonadvanced adenomas were found in 
18.4% of men but only in 9.8% of women. Advanced adenomas were also more likely 
to be present in men than in women (13.5% vs 6.6%). 
Persons with adenomas were significantly older than those without adenomas (59.8 vs 
57.2 yr), and patients with advanced lesions were significantly older than those with 
nonadvanced neoplasms. Adenomas were associated with a significantly higher mean 
BMI (27.4 vs 26.9 kg/m2). Patients with advanced lesions also had a significantly 
higher BMI than those with nonadvanced adenomas. Mean cholesterol levels were 
significantly higher among persons with adenomas than among those without adenomas 
(234.8 vs 228.3 mg/dl), but no significant differences were found in nonadvanced 
versus advanced lesions. There were no differences in the rates of adenomas according 
to the form of recruitment, the presence of nonspecific GI symptoms, bowel habit, daily 
consumption of nonsteroidal anti-inflammatory drugs, or triglycerides serum levels. 
Similar results were found when we considered the “restricted” criteria for advanced 
adenoma (data not shown). 
 
Analysis of Predictive Factors Associated With Advanced Adenomas in Average 
Risk Persons 
In univariate analysis, older age, male sex, and higher BMI were significantly 
associated with a higher probability of advanced adenoma. In the multivariate logistic 
regression model, age, sex, and BMI were shown to be significantly and independently 
associated with advanced lesions (Table 5). The prevalence of advanced adenomas 
increased monotonically with age. When age was introduced as a continuous variable, 
the adjusted OR was 1.05 (95% CI = 1.03– 1.07) for both definitions of advanced 
adenomas (data not shown). Male sex was associated with a significantly higher risk of 
advanced adenomas after adjusting for the other variables in the model (OR = 2.08 for 
the broad definition and OR = 3.64 for the restricted definition). The risk of advanced 
adenomas significantly increased with a higher BMI (adjusted OR for BMI > 30 kg/m2 
= 2.08 for the broad definition and 1.78 for the restricted definition). The adjusted ORs 
for BMI as a continuous variable were 1.06 and 1.04 (broad and restricted definitions, 
respectively). 
 
We also examined the interaction between every two independent variables included in 
the multivariate analyses. None of them showed statistical significance. A score was 
designed as follows. Gender, BMI, and age (the latter two as continuous variables) were 
selected by a stepwise procedure. BMI and age were converted into categoric variables. 
BMI was grouped in 10-point categories (<-25, 26–35, and >35 kg/m2). Age was 
grouped into decades. A new logistic regression model was run with these transformed 
variables. The coefficients yielded by the model were rounded to the nearest half integer 
(0.8 was rounded to 1 and 0.6 to 0.5) and then multiplied by 2 to avoid decimals. The 
coefficients in the model were 0.76, 0.46, and 0.41 for sex, BMI, and age, respectively. 
Therefore, to be male received 2 points (female = 0); each 10 kg/m2 above 25 in BMI 
received 1 point, and the same was applied for each decade above 50 yr (Table 6). 
 
The validity of the score was assessed by ROC analysis. The areas under the ROC curve 
with the logistic models including the original variables were 65.37% and 67.24% for 
both the broad and the restricted criteria used to define advanced adenoma, respectively. 
The loss of validity with the transformed variables was negligible (approximately 1%).  
 
With higher score, the number of persons who should undergo colonoscopic screening 
to detect at least one advanced lesion progressively decreased, as shown in Table 7. 
 
  
 
DISCUSSION 
 
We found that age, gender, and BMI are independent predictors of the risk of advanced 
adenoma in average risk adults, although their predictive value is low. Nevertheless, in 
the absence of better predictors, these variables, which can be easily obtained, might 
help in the selection of more suitable candidates for primary screening colonoscopy. 
 
Most small simple tubular adenomas do not progress to cancer (35). However, 
adenomas with advanced features have been consistently shown to exhibit a greater risk 
of malignant transformation (5). Although adenomas with moderate dysplasia have a 
risk of malignant transformation higher than adenomas with only mild dysplasia (5), 
this characteristic is not considered a feature of advanced adenoma for all authors (6–9, 
15, 17, 18, 36); therefore, we have considered two definitions of advanced adenoma, 
depending on the inclusion or not of moderate dysplasia as a feature of advanced lesion. 
 
Few studies have evaluated variables associated with the presence of advanced colonic 
adenomas in average risk, asymptomatic adults, and limited clinical information is 
available to supplement the findings provided by the screening examinations. Advanced 
disease was present in 11.7% in our series (7.0% if we considered the restricted 
definition for advanced adenoma), a percentage similar to that found in a recent large 
series in the United States (17). To better establish the yield of colonoscopy as a 
primary screening procedure, fecal occult blood testing was not performed before 
endoscopic examination. We carefully screened the subjects included in our analysis to 
ensure that they have neither family history of CRC nor any symptom suggesting high 
risk status. In fact, the prevalence of polyps was unrelated to several other clinical 
variables included in the analyses. Patients with nonspecific abdominal symptoms had 
similar rates of advanced adenomas as asymptomatic patients (10.9% vs 12.2%, p = 
0.34), as reported in some small studies and a recent large series (26–29, 37, 38), and 
there were no differences according to the method used to recruit patients (p = 0.88). 
Altered bowel habit was not a predictor of advanced adenoma in our series. Therefore, 
the prevalence of significant lesions in this population largely reflects the background 
prevalence in asymptomatic populations. 
 
Information on the prevalence of advanced adenomas by age and gender is limited; one 
autopsy series reported a prevalence of large polyps of 4.6% at age greater than 54 yr 
and 15.6% at 75 yr (39). Rex et al. (13) reported that 15% of asymptomatic men and 7% 
of women aged 60 yr or older had advanced colorectal neoplasms. Similar percentages 
had been found in small clinical series and autopsy studies (11, 12, 14, 40–42). We 
found a linear association between age and the prevalence of advanced colonic 
neoplasia. The higher yield of screening colonoscopy in men is consistent with recent 
reports that CRC incidence and mortality are now approximately 1.6-fold greater in men 
than in women (43). 
 
In our series, BMI at screening colonoscopy was an independent predictor of advanced 
adenomas. Studies of obesity and colorectal polyps have presented somewhat 
conflicting findings (22, 24, 44–47). Approximately half of them show a positive 
association between BMI or some other anthropometric measures and large-bowel 
polyps (24, 44, 45). In a recent study, current BMI, the net amount of weight gained 
during the 10 yr before sigmoidoscopy, and the number of large weight changes during 
adulthood were independently associated with colorectal adenomas (48). To our 
knowledge, this is the first report that analyzes BMI as an independent risk factor for 
advanced adenomas in a large population undergoing primary colonoscopic screening. 
Obesity might be a marker for one or more risk factors for CRC. Body weight is largely 
a function of the net effects of energy expenditure and energy intake. Given the 
difficulty of measuring both physical activity and dietary intake accurately, BMI could 
represent a more practical method of determining the cumulative effects of these two 
variables. 
 
A limitation of this study should be emphasized: our sample was biased toward persons 
with medium-to-high socioeconomic status, interested in undergoing CRC screening. 
However, none of these factors is acknowledged as a major determinant of the incidence 
of colorectal neoplasms.  
 
Our data might provide guidance regarding population strategies for CRC screening, as 
well as ground for discussing relative risks with individual patients in clinical settings. 
Population screening colonoscopy for certain subgroups of average risk persons, such as 
men (particularly obese) older than 60 yr, would produce a substantial yield of lesions at 
increased risk for the subsequent development of CRC. 
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Table 1. Characteristics of Patients in This Series 
Age (yr), mean (SD) 57.9 (8.6) 
Male sex, n (%) 1649 (74.6)
Body mass index (kg/m2), mean (SD) 27.0 (3.7) 
Cholesterol (mg/dl), mean (SD) 230 (41.4) 
Triglycerides (mg/dl), mean (SD) 120 (76.3) 
NSAIDs use, n (%)  
No use 2055 (93.0)
Use <1/day 55 (2.5) 
Use ≥1/day 82 (3.7) 
Recruitment method, n (%)  
Routine health check-up 1547 (70.0)
Follow-up of stable medical problems 663 (30.0) 
Nonspecific abdominal pain,* n (%)  
No 1109 (50.2)
Occasional (<1/day/wk) 577 (26.1) 
Frequent (≥1/day/wk) 524 (23.7) 
Bowel habit, n (%)  
Normal (1–2/day) 1519 (68.7)
Chronic diarrhea–alternate 142 (6.5) 
Chronic constipation 549 (24.8) 
Good bowel preparation, n (%) 1229 (55.6)
Sedation, n (%)  
No sedation 426 (19.3) 
Conscious sedation 744 (33.7) 
Deep sedation 1013 (45.8)
NSAIDs = nonsteroidal anti-inflammatory drugs. 
* Patients with persistent abdominal pain developed in 
the year before colonoscopy were excluded from the 
analysis. 
 
 
 
 
 
 
 
 
Table 2. Colonoscopic Findings According to              
the Most Advanced Lesion 
Findings 
   
 
 
n (%) 
Total  2210 (100) 
 No polyps 1385 (62.7) 
 Patients with polyps 825 (37.3)  
Only miscellaneous findings* 60 (2.7)  
 Only hyperplastic polyps 87 (3.9) 
 
Only fulgurated polyps# 61 (2.8)  
 Patients with any colonic adenoma or cancer 617 (27.9) 
 
Findings according to histologic type   
 Tubular adenoma 516 (23.3) 
 
<10 mm 462 (20.9)  
 ≥10 mm 54 (2.4) 
 Villous adenoma 90 (4.0)  
<10 mm 32 (1.4)  
 ≥10 mm 58 (2.6) 
 
Patients with invasive cancer 11 (0.5)  
 Findings according to grade of dysplasia  
 
Mild dysplasia 437 (19.8)  
 <10 mm 379 (17.2) 
 
≥10 mm 58 (2.6≥)  
Moderate dysplasia 153 (6.9)  
 <10 mm 109 (4.9) 
 
≥10 mm 44 (2.0)  
 Severe dysplasia—cancer 27 (1.2) 
 
<10 mm 6 (0.3)  
 ≥10 mm 21 (0.9) 
 
Any advanced adenoma   
 Broad definition 259 (11.7) 
 Restricted definition 156 (7.0)  
 * Miscellaneous findings: normal mucosa, chronic nonspecific 
inflammation, inflammatory or juvenile polyps, lymphoid 
aggregates, lipomas. 
# In 61 patients, diminutive colonic polyps (always <5 mm) 
became totally fulgurated during resection with polypectomy 
snare, and histology was not known. 
 
 
 
 
 
 
 
Table 3. Prevalence and Location of Advanced Neoplasms in the 
Study Population (N = 2210). 
n (%) 
Broad 
Definition 
Restricted 
Definition 
Location of Advanced Neoplasms 259 (11.7) 156 (7.0) 
Only in distal colon* 137 (52.9) 100 (64.1) 
Only in proximal colon* 68 (26.3) 37 (23.7) 
Both proximal and distal colon 54 (20.8) 19 (12.2) 
* Adenomas were defined as distal if they came from the descending 
colon or more distally (in the sigmoid colon or rectum). Otherwise,
the polyps were designated as proximal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Comparative Characteristics of Patients Regarding the Presence and Kind          
of Colonic Adenomas. 
 Absence of Adenomas 
Only 
Non-Advanced
Adenomas 
Advanced 
Adenomas* p
#
Total 1593 (72.1) 358 (16.2) 259 (11.7) 
Categoric variables      
Sex    <0.001
Male 1124 (68.2) 303 (18.4) 222 (13.5)  
Female 469 (83.6) 55 (9.8) 37 (6.6)  
NSAIDs daily    0.220 
No 1517 (71.9) 342 (16.2) 251 (11.9)  
Yes 64 (78.0) 11 (13.4) 7 (8.5)  
Form of recruitment    0.882 
Routine medical check-up 1113 (71.9) 257 (16.6) 177 (11.4)  
Other causes 480 (72.4) 101 (15.2) 82 (12.4)  
Nonspecific abdominal pain    0.343 
No 787 (71.0) 187 (16.9) 135 (12.2)  
Occasional 425 (73.7) 85 (14.7) 67 (11.6)  
Frequent 381 (72.7) 86 (16.4) 57 (10.9)  
Bowel habit    0.788 
1–2 movements/day 1086 (71.5) 257 (16.9) 176 (11.6)  
Diarrhea–alternate 109 (76.8) 16 (11.3) 17 (12.0)  
Chronic constipation 398 (72.5) 85 (15.5) 66 (12.0)  
Continuous variables     
Age (yr) 57.2 (8.6) 58.8 (8.4) 61.2 (8.5) <0.001‡
    0.001§
BMI (kg/m2) 26.9 (3.7) 27.0 (3.6) 27.9 (3.4) 0.005‡
    0.015§
Cholesterol (mg/dl) 228.3 (41) 233.7 (40.8) 236.6 (44.0) 0.001‡
    0.454§
Triglycerides (mg/dl) 118.6 (77.7) 127.0 (78.5) 121.4 (63.2) 0.155‡
    0.395§
Data are presented as n (%) for categoric variables, mean (SD) for continuous variables. 
* Advanced adenoma: any adenoma ≥1 cm and/or tubulovillous–villous and/or with moderate–
severe dysplasia. 
# Comparisons of categoric variables were established by χ2 test for linear trend. Comparisons 
of continuous variables were done with a priori contrasts in one-way ANOVA test. 
‡ Compares persons without adenomas versus persons with any colonic adenoma. 
§ Compares persons with non-advanced adenomas versus persons with at least one advanced 
lesion. 
 
 
 
 
 
 
 
Table 5. Analysis of Predictive Factors Associated With Advanced Colonic Adenomas in           
Average-Risk Persons 
 % Patients With Advanced Crude OR (95% CI) Adjusted OR (95% CI) 
Variable Mode   1A 
Mode 
1B Model A Model B Model A Model B 
Age (yr)       
≤550 5.4 3.1 1 1 1 1 
51–60 10.6 6.1 2.07 (1.3–3.3) 2.01 (1.1–3.7) 1.82 (1.1–3.0) 1.98 (1.0–3.8)
61–70 14.9 9.2 3.06 (1.9–4.8) 3.12 (1.7–5.6) 2.49 (1.5–4.1) 2.84 (1.5–5.5)
>70 20.8 12.9 4.60 (2.7–7.9) 4.57 (2.3–9.1) 3.94 (2.1–7.3) 4.72 (2.2–10.3)
Sex       
Female 6.6 3.0 1 1 1 1 
Male 13.5 8.4 2.51 (1.5–3.1) 2.94 (1.8–4.9) 2.08 (1.3–3.2) 3.64 (1.9–7.1)
BMI (kg/m2)       
≤25 7.4 4.5 1 1 1 1 
26–30 12.5 7.7 1.78 (1.2–2.6) 1.74 (1.1–2.9) 1.56 (1.0–2.3) 1.43 (0.8–2.4)
>30 16.1 9.5 2.39 (1.5–3.8) 2.20 (1.2–3.9) 2.08 (1.3–3.3) 1.78 (1.0–3.2)
Model A: “broad definition” for advanced adenoma: any adenoma ≥10 mm and/or with villous 
component and/or with moderate or severe dysplasia. Model B: “restricted definition” for advanced 
adenoma: moderate dysplasia is excluded as a feature of advanced lesion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Estimation of the Score 
Variable Level Score 
Sex Male Female 
2 
0 
BMI (kg/m2) 
≤25 
25–35 
>35 
0 
1 
2 
Age (yr) 
≤50 
51–60 
61–70 
71–80 
>80 
0 
1 
2 
3 
4 
 
 
 
Table 7. Diagnostic Yield of Colonoscopy for Advanced Adenomas 
 
Advanced Colonic 
Adenomas        
(n) 
 
Score No Yes % with advanced adenomas PPV NNS 
Broad definition for advanced colonic adenoma 
0 41 0 0 12.0 8.3 
1 109 8 7 12.4 8.1 
2 195 6 3 13.8 7.2 
3 371 37 9 15.9 6.3 
4 418 69 14 17.9 5.6 
5 299 60 17 23.4 4.3 
6 56 15 21 50.0 2.0 
7 3 3 50
Restricted definition for advanced colonic adenoma 
0 41 0 0 7.3 13.7 
1 116 1 1 7.8 12.9 
2 197 4 2 8.6 11.6 
3 388 20 5 10.3 9.7 
4 442 45 9 11.5 8.7 
5 322 37 10 16.7 6.0 
6 60 11 15 33.3 3.0 
7 4 2 33
► NNS = number needed to screen (the number of patients who 
would have to undergo colonoscopic screening to identify one 
patient with at least one advanced neoplasm). 
► PPV = positive predictive value. 
 
